Effect of triiodothyronine on hyperandrogenism in women by unknown
MEETING ABSTRACT Open Access
Effect of triiodothyronine on hyperandrogenism
in women
Gintautas Kazanavicius*, I Purtokaite-Labutiniene, D Kozloviene, V Kruminis, E Kreivaitiene
From 4th Congress of the Polish Thyroid Association 2013
Lodz, Poland. 11-13 April 2013
Introduction
The imbalance of thyroid hormones can cause the dys-
function of the reproductive system. The aim of our study
is to evaluate the thyroid hormone triiodthyronine’s (T3)
influence on women’s hyperandrogenism.
Methods
42 women aged 18-35 were randomly selected with FAI
> 4.5 or one of the following signs of hyperandrogenism:
hirsutism, acne, menstrual disorder, with normal thyroid
function. Patients were divided into two groups. The
first group (n=23) received 12.5µg of T3 for 6 months
and the second group (n=19) – placebo. After the
6-month course the treatment was changed accordingly.
We estimated hirsutism by using the Ferriman–Gallwey
score system, acne, testosterone (T) levels, sex hormone
binding globulin (SHBG) and free androgen index (FAI)
and we also examined ovarian volume changes.
Results
The hirsutism score decreased from 11.86±6.17 to 8.44
±5.02 (p=0.009). A significant decline of acne score was
observed from 1.66 to 0.58 (p=0.02). The testosterone
serum level dropped from 2.85±1.29 ng/l to 2.28±0.87
ng/l (p=0.03) and SHBG serum concentration during the
6-month period increased from 34.99±15.34 nmol/l up to
44.52±19.69 nmol/l (p≤0.03). FAI decreased from 10.11
±7.29 to 6.48±4.62 (p≤0.007). The TSH level after 3
months of treatment decreased from 1.69±0.93 mIU/l to
0.82±0.69 mIU/l (p<0.001) and after 6 months was 1.15
±0.9 mIU/l (p<0.01). The FT4 level dropped from 15.52
pmol/l to 10.51±2.12 pmol/l (p<0.05). The FT3 level
increased from 4.73±0.69 pmol/l to 7.57±1.86 pmol/l
(p<0.05). The thyroid gland volume during the treatment
remained stable. The ovarian volume over 6 months
changed from 25.3±9.3 to 18.36±6.25 (p=0.002). A positive
correlation was found between the ovarian volume and T
serum level r=0.47 (p<0.001) together with FAI level
r=0.429 (p<0.001). The weight loss was observed in some
of the women during the T3 treatment course. In this
group the weight and ovarian volume remained stable
after six months of not receiving drug treatment. Also in
this group the decrease of oestrogen was seen during and
over half a year after treatment. The oestrogen level for
the group of women whose weight was stable or increased
during the treatment, at the beginning, was lower, and
during the course increased from 165.1±80 pg/ml to
205.7±99.4 pg/ml. Finally the oestrogen level significantly
increased to 288.9±223.5 pg/ml (p<0.03) after six months
of no T3 treatment. The difference in ovarian volume
between these two groups according to the weight changes
was statistically proven p=0.008. The ovarian volume
decreased only during the treatment of women with the
same or bigger weight, compared with the group with
weight loss where the ovarian volume remained smaller
after discontinuation of the treatment. Also the T3 impact
on androgens after discontinuation of treatment was
determined only for women with weight loss.
Conclusions
Hirsutism, acne, androgens and ovarian volumes are
decreased due to the increase of the triiodothyronine level
in blood of women with hyperandrogenism signs. The
long-term (6 months) clinical effect of T3 is observed in
women with weight loss during treatment.
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